Exit Ramp: Arsenal-Backed Polyventive Primed for Sale
The private equity firm has signaled a desire to exit the chemicals company before the end of 2022, sources say, as it remains the final piece of a 2015 platform still in Arsenal's portfolio.
Up-to-the-minute alerts and analytical intelligence focused on potential and announced transactions as well as the people behind them.